338 related articles for article (PubMed ID: 26431609)
1. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
2. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
3. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
4. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
6. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
Bestawros A; Boulassel MR; Michel RP; Routy JP
J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
[No Abstract] [Full Text] [Related]
7. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
[TBL] [Abstract][Full Text] [Related]
9. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
10. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Wen KW; Damania B
Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
[TBL] [Abstract][Full Text] [Related]
12. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
Katano H; Sato Y; Kurata T; Mori S; Sata T
Virology; 2000 Apr; 269(2):335-44. PubMed ID: 10753712
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8 infections in patients with immunodeficiencies.
Laurent C; Meggetto F; Brousset P
Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
[TBL] [Abstract][Full Text] [Related]
15. Serous fluid cytology of multicentric Castleman's disease and other lymphoproliferative disorders associated with Kaposi sarcoma-associated herpes virus: a review with case reports.
Lobo C; Amin S; Ramsay A; Diss T; Kocjan G
Cytopathology; 2012 Apr; 23(2):76-85. PubMed ID: 21658135
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
17. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
18. KSHV-Mediated Angiogenesis in Tumor Progression.
Purushothaman P; Uppal T; Sarkar R; Verma SC
Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8 virology, epidemiology and related diseases.
Katano H; Sata T
Jpn J Infect Dis; 2000 Aug; 53(4):137-55. PubMed ID: 11056556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
